To compare integrated and separated ECMO-CRRT configurations and assess their impact on CRRT circuit lifespan and safety outcomes, highlighting the significance of this comparison in clinical practice.
Key Findings:
CRRT circuit lifespan did not differ significantly between integrated and separated groups, with a median duration of approximately 72 hours, indicating comparable performance.
Safety outcomes, including serious adverse events and 28-day mortality, were comparable between both strategies, suggesting no increased risk with either approach.
Access and return pressures were higher in the integrated group, but this did not lead to increased transmembrane pressures or premature circuit failure, indicating effective management of pressures.
Interpretation:
The E-CRRT trial suggests that CRRT performance during ECMO may depend more on clinical practices than on the connection method itself, with both strategies showing comparable technical performance, emphasizing the role of clinical expertise.
Limitations:
The study primarily involved patients on venoarterial ECMO, limiting applicability to venovenous ECMO, and the crossover design may affect the interpretation of the results, as many patients allocated to separation switched to integration due to vascular access issues, potentially biasing outcomes.
Conclusion:
Both integrated and separated CRRT strategies can achieve similar outcomes when applied by experienced teams, but the choice of strategy may be influenced by vascular access limitations and clinical practices, underscoring the need for tailored approaches in ECMO settings.
